Cardiovascular research technologies 2012

P and T

Volumn 37, Issue 3, 2012, Pages 186-189

  Alexander, Walter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE P2Y12 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PRASUGREL; RECEPTOR BLOCKING AGENT; STREPTOKINASE; TICAGRELOR; TICLOPIDINE; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; BLEEDING; CLINICAL TRIAL (TOPIC); DIARRHEA; DRUG APPROVAL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; HEALTH CARE PERSONNEL; HEART INFARCTION; HUMAN; ISCHEMIA; LOADING DRUG DOSE; NAUSEA; NEUTROPENIA; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; RASH; REVIEW; STENT THROMBOSIS; STOMACH DISEASE; THROMBOCYTE AGGREGATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 84859184600     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (1)

1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 (2nd International Study of Infarct Survival Collaborative Group). Lancet 1988;2(8607):349-360.